Skip to main content
KARD
NASDAQ Life Sciences

Kardigan Shares Soar 38% on Nasdaq Debut After $400M Upsized IPO

Tom Rudovsky · Reported by Binance News
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$22
Mkt Cap
--
52W Low
--
52W High
--
52W Position
Off High
Rel. Volume
Market data snapshot near publication time

Summary

Kardigan's stock surged 38% in its Nasdaq trading debut, following an upsized initial public offering that raised $400 million. This strong first-day performance significantly exceeds earlier reports of a modest gain. The heart-health biotech priced 25 million shares at $16.00 each, indicating robust investor demand for the new issue.

At the time of this announcement, KARD was trading at $22.00 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Binance News.


Price Chart

Share this article

Copied!

KARD - Latest Insights

KARD
Nov 12, 2026, 7:02 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $15.68
Real-time Price: $13.82 info
Change: -$1.86 (-12%) info
Market Cap: $1.292B info
KARD
Nov 06, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.93
Real-time Price: $13.82 info
Change: -$2.11 (-13%) info
Market Cap: $1.292B info
KARD
Nov 06, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $15.52
Real-time Price: $13.82 info
Change: -$1.70 (-11%) info
Market Cap: $1.292B info
KARD
Aug 11, 2026, 7:10 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $13.82 info
Change: -$6.59 (-32%) info
Market Cap: $1.292B info
KARD
Aug 11, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $13.82 info
Change: -$6.59 (-32%) info
Market Cap: $1.292B info